Search research articles
Contact Us
Filters
Showing results (51-60 of 112) with videos related to
Page
of 12
Sort By:
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
June 22, 2016
Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA)
Fizza Arain, Lars Gullestad, Ståle Nymo, et al.
The American Journal of Cardiology
|
January 13, 2004
The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
Cynthia J Girman, Thomas Rhodes, Michele Mercuri, et al.
European Heart Journal
|
April 23, 2009
Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial
Stefan D Anker, Adriaan Voors, Darlington Okonko, et al.
Circulation. Heart Failure
|
November 29, 2013
Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial
Jørgen Gravning, Erik T Askevold, Ståle H Nymo, et al.
Journal of the American College of Cardiology
|
January 18, 2005
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF)
Lars Gullestad, John Wikstrand, Prakash Deedwania, et al.
Diabetes Care
|
June 29, 2004
Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S)
Kalevi Pyörälä, Christie M Ballantyne, Barry Gumbiner, et al.
Journal of the American College of Cardiology
|
November 16, 2004
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction
Thor Ueland, Rune Jemtland, Kristin Godang, et al.
Journal of Cardiac Failure
|
October 19, 2006
Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction
Thor Ueland, Terje Espevik, John Kjekshus, et al.
European Journal of Heart Failure
|
February 17, 2015
Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF
Matthew J Feinstein, Pardeep Jhund, Joseph Kang, et al.
Transplantation
|
November 27, 2002
Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension
Torbjørn Holm, Pål Aukrust, Erik Aagaard, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 112) with videos related to
Sort By:
Page
of 12
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
June 22, 2016
Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA)
Fizza Arain, Lars Gullestad, Ståle Nymo, et al.
The American Journal of Cardiology
|
January 13, 2004
The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
Cynthia J Girman, Thomas Rhodes, Michele Mercuri, et al.
European Heart Journal
|
April 23, 2009
Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial
Stefan D Anker, Adriaan Voors, Darlington Okonko, et al.
Circulation. Heart Failure
|
November 29, 2013
Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial
Jørgen Gravning, Erik T Askevold, Ståle H Nymo, et al.
Journal of the American College of Cardiology
|
January 18, 2005
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF)
Lars Gullestad, John Wikstrand, Prakash Deedwania, et al.
Diabetes Care
|
June 29, 2004
Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S)
Kalevi Pyörälä, Christie M Ballantyne, Barry Gumbiner, et al.
Journal of the American College of Cardiology
|
November 16, 2004
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction
Thor Ueland, Rune Jemtland, Kristin Godang, et al.
Journal of Cardiac Failure
|
October 19, 2006
Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction
Thor Ueland, Terje Espevik, John Kjekshus, et al.
European Journal of Heart Failure
|
February 17, 2015
Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF
Matthew J Feinstein, Pardeep Jhund, Joseph Kang, et al.
Transplantation
|
November 27, 2002
Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension
Torbjørn Holm, Pål Aukrust, Erik Aagaard, et al.
Page
of 12